AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

October 15, 2024

Period of Report

October 9, 2024

Accession Number

0001096906-24-002002

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →